Skip to main content
TipRanks
Go Ultimate75% OFF

Brookdale Senior Living (B7S) AI Stock Analysis

0 Followers
DE:B7S

Brookdale Senior Living

(Frankfurt:B7S)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
EBITDA Growth and Labor ProductivityImproving EBITDA and labor productivity indicate that Brookdale is converting operational initiatives into stronger earnings capacity. If these gains persist, better staffing efficiency and margin discipline can support cash generation and provide a durable foundation for growth despite occupancy volatility.
Negative Factors
Negative Equity and Elevated LeverageNegative equity signals weak capitalization and limits financial flexibility, while debt remains substantial relative to current earnings. This leaves Brookdale more exposed to operating setbacks and can constrain investment, refinancing choices, and the company’s ability to absorb prolonged underperformance.

Brookdale Senior Living (B7S) vs. iShares MSCI Germany ETF (EWG)

-20%-10%0%10%20%30%40%50%60%DE:B7S-10.44%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 2.19B
Dividend Yield
―
Average Volume (3M)
153
Price to Earnings (P/E)
-57.7
Beta (1Y)
0.09
Revenue Growth
-14.44%
EPS Growth
89.47%
Country
Germany
Employees
33,000
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Brookdale Senior Living Business Overview & Revenue Model

Company Description

Brookdale Senior Living Inc., founded in 2005 and based in Brentwood, Tennessee, specializes in the ownership, operation, and management of senior residential communities across the United States. Its services are structured into three distinct divis...

Brookdale Senior Living Earnings Call Summary

Earnings Call Date:Nov 06, 2026(Q3-2026)|% Change Since:-14.66%|Next Earnings Date:Feb 23, 2027
Earnings Call SentimentPositive

The call was broadly constructive, with adjusted EBITDA growth, improved labor productivity, portfolio optimization, higher CapEx investment, strong lead conversion, and continued confidence in 2027 growth. However, management lowered 2026 guidance because occupancy growth fell short of expectations, while subdued lead volume, elevated facility expenses, the Clinton fire, and slightly lower liquidity remained notable challenges.

Positive Updates

Adjusted EBITDA Growth Met Expectations
Third-quarter adjusted EBITDA was $124.3 million, up 12% versus the prior-year quarter and in line with the company's expected low-double-digit growth pacing.

Negative Updates

2026 Adjusted EBITDA and RevPAR Guidance Reduced
Brookdale lowered full-year 2026 adjusted EBITDA guidance to $495 million to $502 million and reduced full-year consolidated RevPAR growth guidance to 7.4% to 7.9%. The revised outlook primarily reflects weaker-than-expected occupancy growth during the summer selling season.

Company Guidance

Brookdale now expects full year 2026 adjusted EBITDA of $495 million to $502 million and full year consolidated RevPAR year-over-year growth of 7.4% to 7.9%, with fourth quarter RevPAR growth in the high-6% range and fourth quarter adjusted EBITDA growth at a low double digit to mid teen year over year growth rate; full year consolidated occupancy is expected to come in below 83%, full year G&A cost is expected to be approximately $154 million, cash facility operating lease payments are expected to be $172 million, and management fees are expected to be approximately $7 million, with assumptions including occupancy growth remains muted during the fourth quarter, rate remains relatively firm in the fourth quarter, the impact of the remaining dispositions will be minimal, continued labor expense improvement, slightly elevated other facility operating expenses, and the current estimates of the fourth quarter revenue and expense impact of the recent fire at the 97-unit Clinton, Mississippi community; Brookdale remains confident in its ability to create durable, mid teens adjusted EBITDA growth in 2027 and beyond.

Brookdale Senior Living Risk Analysis

Brookdale Senior Living disclosed 37 risk factors in its most recent earnings report. Brookdale Senior Living reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Brookdale Senior Living Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:B7S against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ENSGENSG75Outperform$10.99B27.2716.63%0.14%17.49%19.82%
PACSPACS71Outperform$7.67B27.6125.77%―11.02%62.56%
NHCNHC68Neutral$3.26B28.2110.41%1.26%5.71%12.44%
PNTGPNTG61Neutral$1.27B34.6810.15%―38.67%33.07%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SNDASNDA45Neutral$1.62B-6.17-19.40%―69.98%-86.89%

* Healthcare Sector Average

Performance Comparison

0%50%100%150%200%DE:B7SSNDANHCENSGPNTGPACSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:B7S and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:B7SBrookdale Senior Living Inc.8.15-0.90-9.94%
SNDASonida Senior Living, Inc.33.000.993.09%
NHCNational Healthcare207.9383.9167.66%
ENSGThe Ensign188.4111.116.27%
PNTGPennant Group Inc36.0710.6742.01%
PACSPACS Group Inc48.3232.62207.77%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.